4//SEC Filing
Mahal Jeetinder Singh 4
Accession 0001213900-23-048683
CIK 0001788028other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 8:54 PM ET
Size
9.5 KB
Accession
0001213900-23-048683
Insider Transaction Report
Form 4
Mahal Jeetinder Singh
Chief Operating Officer
Transactions
- Exercise/Conversion
Voting Common Stock
2023-06-13$0.71/sh+9,000$6,390→ 296,223 total - Sale
Voting Common Stock
2023-06-13$1.66/sh−9,000$14,915→ 287,223 total - Exercise/Conversion
Stock Option (right to buy)
2023-06-13+9,000→ 173,713 totalExercise: $0.71Exp: 2030-05-31→ Voting Common Stock (9,000 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.69, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- [F3]25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares have vested and shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001882877
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 8:54 PM ET
- Size
- 9.5 KB